Skip to content
Peregrine
  • Home
  • About Us
    • Company Overview
    • Our Mission
  • Our Funds
  • Portfolio
  • Team
  • ESG & Impact
  • News
  • Contact
  • Home
  • About Us
    • Company Overview
    • Our Mission
  • Our Funds
  • Portfolio
  • Team
  • ESG & Impact
  • News
  • Contact

News

Restore Medical secures $23 million Series B; two global strategics join the round

Restore Medical secures $23 million Series B; two global strategics join the round

Read More
Merck joins Incentive incubator as strategic partner

Merck joins Incentive incubator as strategic partner

Read More
start up nation Most active investor 2024 Healthcare

Peregrine Ventures recognized as Israel’s most active healthtech investor

Read More
Endostream Kaneka

EndoStream Medical acquired by Kaneka corporation

Read More
Bio ReFine

Bio ReFine™ achieves First-in-Human success with Coriofix™ system

Read More
Momentis Surgical robotic platform

Momentis Surgical™ achieves two FDA clearances in two weeks

Read More
Nectin Therapeutics Secures Global License Agreement with Immunome, Inc.

Nectin Therapeutics secures global license agreement with Immunome, Inc.

Read More
Cordio Medical

Cordio Medical partners with Iron Nation

Read More
Restore Medical, FDA

Restore Medical receives FDA Breakthrough Device Designation for the ContraBand™ System

Read More
DairyX receives 1.5 million ILS grant from Israel Innovation Authority

DairyX receives 1.5 million ILS grant from Israel Innovation Authority

Read More
Page1 Page2 Page3 Page4 Page5
  • Homepage
  • About Us
  • Our Funds
  • Portfolio
  • Team
  • ESG AND IMPACT
  • News
  • Contact
  • Homepage
  • About Us
  • Our Funds
  • Portfolio
  • Team
  • ESG AND IMPACT
  • News
  • Contact
Linkedin-in
  • Terms of Use
  • Privacy Policy
  • Accessibility Statment
  • Cookie Policy
  • Terms of Use
  • Privacy Policy
  • Accessibility Statment
  • Cookie Policy
©All rights reserved to Peregrine 2026

site by: 

razgroup-logo
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}